CME Group (CME) Given Daily Media Impact Score of 0.15

News stories about CME Group (NASDAQ:CME) have been trending somewhat positive on Friday, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.166583858726 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

Shares of CME Group (CME) traded up $0.65 on Friday, reaching $151.07. The company had a trading volume of 2,241,081 shares, compared to its average volume of 1,378,550. The stock has a market cap of $51,410.00, a PE ratio of 31.72, a price-to-earnings-growth ratio of 3.11 and a beta of 0.73. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a twelve month low of $113.27 and a twelve month high of $155.29.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.05 EPS. research analysts predict that CME Group will post 4.78 earnings per share for the current year.

The business also recently disclosed a dividend, which will be paid on Tuesday, January 16th. Investors of record on Thursday, December 28th will be issued a dividend of $3.50 per share. This is a boost from CME Group’s previous dividend of $3.25. The ex-dividend date of this dividend is Wednesday, December 27th. CME Group’s dividend payout ratio is 59.86%.

A number of brokerages have recently commented on CME. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 6th. Barclays upped their price target on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research report on Tuesday, October 10th. Wells Fargo & Company upped their price target on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. Royal Bank of Canada upped their price target on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. Finally, Citigroup upped their price target on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, October 19th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. CME Group has an average rating of “Buy” and an average price target of $141.75.

In other CME Group news, insider Julie Winkler sold 2,457 shares of the company’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $150.41, for a total value of $369,557.37. Following the transaction, the insider now directly owns 16,318 shares in the company, valued at approximately $2,454,390.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hilda Harris Piell sold 1,350 shares of the company’s stock in a transaction dated Thursday, October 5th. The stock was sold at an average price of $138.00, for a total value of $186,300.00. The disclosure for this sale can be found here. Insiders have sold a total of 36,628 shares of company stock worth $5,288,800 in the last three months. 0.57% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “CME Group (CME) Given Daily Media Impact Score of 0.15” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://ledgergazette.com/2017/12/15/cme-group-cme-given-daily-media-impact-score-of-0-15.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply